CD Genomics is pleased to introduce the Nanopore cDNA & Iso-seq Full-length Transcriptome Analysis service, which helps researchers obtain complete and accurate information on gene expression and regulation by using state-of-the-art Oxford Nanopore Technology to produce long reads that span the entire length of transcripts.
Shirley, New York, United States – May 6, 2023 /MarketersMEDIA/ —
Bioinformatics-Analysis is a subdivision of CD Genomics, providing reliable next-generation and third-generation high-throughput sequencing data analysis, database construction, and other related data analysis services utilizing comprehensive technology. The Product Manager at CD Genomics is pleased to introducethe Nanopore cDNA & Iso-seq Full-length Transcriptome Analysis service, which helps researchers to obtain complete and accurate information on gene expression and regulation by using state-of-the-art Oxford Nanopore Technology to produce long reads that span the entire length of transcripts.
The Nanopore cDNA & Iso-seq Full-length Transcriptome Analysis service is based on two distinct but complementary techniques: cDNA synthesis and Iso-Seq sequencing. The cDNA libraries are then sequenced on the Nanopore platform, which generates long reads of up to several tens of kilobases in length. Finally, the long reads are processed and analyzed to identify full-length transcripts, splice variants, and other transcriptomic features.
The newly-developed service has several advantages over traditional short-read sequencing technologies. For example, the long reads generated by the Nanopore platform allow for the detection of full-length transcripts, as well as the identification of alternative splicing events and other transcriptomic features that are difficult to detect using short reads. Additionally, the Nanopore platform produces highly accurate reads with low error rates, reducing the need for extensive error correction.
Compared to traditional short-read sequencing technologies, CD Genomics’ Nanopore cDNA & Iso-seq Full-length Transcriptome Analysis service offers several advantages. First, the long reads generated by the Nanopore platform enable the detection of full-length transcripts and the identification of alternative splicing events and other transcriptomic features that are often missed by short reads. Second, the Nanopore platform produces highly accurate reads with low error rates, reducing the need for extensive error correction.
“We are excited to offer the Nanopore cDNA & Iso-seq Full-length Transcriptome Analysis service to our customers,” said a spokesperson for CD Genomics. “This technology has the potential to revolutionize the field of transcriptomics by providing researchers with complete and accurate information on gene expression and regulation. We believe that this service will enable researchers to make significant advances in fields such as cancer research, developmental biology, and neurobiology.”
CD Genomics is committed to providing its customers with the latest cutting-edge technologies in genomics research. In addition to the Nanopore cDNA & Iso-seq Full-length Transcriptome Analysis service, the company offers a comprehensive range of genomics services, including DNA sequencing, RNA sequencing, microbiome analysis, and more.
About CD Genomics
With a high-performance computing platform and a bioinformatics analysis team dominated by Ph.D. and Master’s education, CD Genomics is the second-to-none provider of bioinformatics analysis services. The company takes advantage of cutting-edge bioinformatics technologies to conduct research in genomics, transcriptomics, microorganisms, epigenetics, proteomics, metabolomics, single-cell omics, and more.
Contact Info:
Name: Kiko Garcia
Email: Send Email
Organization: CD Genomics
Website: https://bioinfo.cd-genomics.com/
Release ID: 89096936
If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us. We will respond and rectify the situation in the next 8 hours.